Nivolumab vs Pravastatin
Nivolumab vs Pravastatin: Overview
This comparison examines the pharmacological differences between Nivolumab and Pravastatin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Pravastatin — 1.8 hours.
Chemical Properties
Molecular Formula: Pravastatin — C23H36O7.
Molecular Weight: Pravastatin — 424.5280 g/mol.
Type: Nivolumab — Antibody; Pravastatin — Small molecule.